US Pharmacopeia Opens New Headquarters
The US Pharmacopeia (USP) held an official grand opening celebration on March 3, 2008, for its new global headquarters in Rockville, MD.
The US Pharmacopeia (USP) held an official grand opening celebration on March 3, 2008, for its new global headquarters in Rockville, MD. The new buildings, for which construction began in 2004, includes a 141,000-square foot office building that houses three laboratories, and a separate 16,000-square foot meeting center with a 273-seat auditorium, five meeting rooms, and state-of-the-art training center. The USP says that its new headquarters will help the organization continue to build on its core mission of setting official quality standards for prescription and over-the-counter medications in the US, while expanding to set standards for the quality of food ingredients and dietary supplements. In an effort to expand and strengthen its international presence, USP has also opened facilities in Europe, India, and China over the past three years, and another facility will open in Sao Paolo, Brazil, in August 2008.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 2nd 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
August 2nd 2025In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
